People · Operator
Named in public records as an officer, director or promoter · active 2010–2016 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Transcend Medical Inc | — | Other Health Care | Series B | $122.3M | $648.4M | 2011 |
| Agile Therapeutics Inc | — | Pharmaceuticals | Series B | $89.6M | $266.5M | 2010 |
| TearScience, Inc. | — | Pharmaceuticals | Series B | $58.9M | $653.7M | 2016 |
Abhijeet Lele at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Abhijeet Lele on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joel Cutler | 1 | 16 |
| Wende Hutton | 1 | 16 |
| Todd Davis | 1 | 8 |
| Reza Zadno | 1 | 7 |
| Brian Walsh | 1 | 7 |
| Immanuel Thangaraj | 1 | 6 |
| David Stassen | 1 | 5 |
| David W. Stassen | 1 | 5 |
| Joe Mandato | 1 | 5 |
| K. Angela Macfarlane | 1 | 5 |
| Andrew Schiff | 1 | 5 |
| Al Wiegman | 1 | 5 |
| Eugene De Juan, Jr., M.D. | 1 | 4 |
| Geoff R. Pardo | 1 | 4 |
| Karen Hong | 1 | 4 |
| Robert C. Bellas, Jr. | 1 | 4 |
| Jim Glasheen | 1 | 3 |
| Russell W. Ayres | 1 | 2 |
| Al M. Altomari | 1 | 2 |
| Paul J. Schmitt | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.